Related Experiment Video

Updated: Jul 18, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Prevention strategies for type 1 diabetes

Christopher M Kishiyama1, H Peter Chase, Jennifer M Barker

  • 1The Barbara Davis Center for Childhood Diabetes, Denver, CO, USA. christopher.kishiyama@uchsc.edu

Reviews in Endocrine & Metabolic Disorders
|December 21, 2006
PubMed

Insights

Preventing Type 1 diabetes (T1D) remains challenging. This review explores past, present, and future strategies for T1D prevention in at-risk individuals, those with antibodies, and new-onset cases.

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) is a prevalent chronic childhood disease with significant complication risks.
  • Advances in understanding T1D genetics, environment, and natural history have improved etiology and epidemiology knowledge.
  • Technological progress has enhanced glycemic control and complication reduction in T1D patients.

Purpose of the Study:

  • To review historical, current, and emerging strategies for preventing Type 1 diabetes.
  • To identify prevention approaches for distinct patient groups: those at risk for autoimmunity, those with autoantibodies, and those with new-onset T1D.

Main Methods:

  • Comprehensive literature review of T1D prevention strategies.
  • Analysis of studies focusing on genetic, environmental, and immunological factors.
  • Evaluation of technological advancements impacting T1D management and prevention.

Main Results:

  • Despite improved understanding and management, primary prevention of T1D development is not yet achieved.
  • Various strategies are being investigated across different stages of T1D development.
  • Technological advancements offer improved glycemic control but do not prevent disease onset.

Conclusions:

  • Prevention of Type 1 diabetes remains a critical unmet need.
  • A multi-faceted approach targeting autoimmunity, antibody production, and early disease stages is necessary.
  • Future research should focus on translating current knowledge into effective T1D prevention therapies.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...